
January to March 2024
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| PEMBROLIZUMAB | $157,870,600 | 18,621 |
| ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR | $125,677,479 | 5,879 |
| MOLNUPIRAVIR | $120,061,346 | 103,404 |
| NIVOLUMAB | $112,726,074 | 15,588 |
| USTEKINUMAB | $109,426,606 | 15,229 |
| AFLIBERCEPT | $107,119,548 | 109,489 |
| DUPILUMAB | $92,293,671 | 53,802 |
| NIRMATRELVIR (&) RITONAVIR | $84,449,271 | 68,981 |
| APIXABAN | $79,716,647 | 982,101 |
| DENOSUMAB | $70,313,774 | 280,520 |
| ADALIMUMAB | $65,543,564 | 90,944 |
| SEMAGLUTIDE | $65,163,857 | 561,880 |
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| ROSUVASTATIN | $21,906,424 | 3,971,099 |
| ATORVASTATIN | $16,761,315 | 2,753,373 |
| PANTOPRAZOLE | $15,172,130 | 2,561,713 |
| ESOMEPRAZOLE | $13,309,151 | 1,930,652 |
| PERINDOPRIL | $8,966,174 | 1,632,024 |
| ESCITALOPRAM | $5,502,193 | 1,566,508 |
| SERTRALINE | $5,684,257 | 1,467,350 |
| METFORMIN | $8,066,302 | 1,407,296 |
| CEFALEXIN | $5,435,667 | 1,286,454 |
| AMLODIPINE | $6,237,855 | 1,135,784 |
| TELMISARTAN | $5,429,898 | 1,056,328 |
| AMOXICILLIN | $3,482,983 | 1,019,109 |
| Contributor | Contribution Dollars |
|---|---|
| Australian Government | $4,286,500,464 |
| Patients | $991,285,483 |